Stockreport

Clene to Participate at the Benchmark 14th Annual Discovery One-on-One Investor Conference

Clene Inc.  (CLNN) 
PDF SALT LAKE CITY, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine I [Read more]